These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33752217)

  • 1. Variants in ACE2 and TMPRSS2 Genes Are Not Major Determinants of COVID-19 Severity in UK Biobank Subjects.
    Curtis D
    Hum Hered; 2020; 85(2):66-68. PubMed ID: 33752217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain.
    Torre-Fuentes L; Matías-Guiu J; Hernández-Lorenzo L; Montero-Escribano P; Pytel V; Porta-Etessam J; Gómez-Pinedo U; Matías-Guiu JA
    J Med Virol; 2021 Feb; 93(2):863-869. PubMed ID: 32691890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of ACE2 and TMPRSS2 coding variants as a risk factor for SARS-CoV-2 from 946 whole-exome sequencing data in the Turkish population.
    Duman N; Tuncel G; Bisgin A; Bozdogan ST; Sag SO; Gul S; Kiraz A; Balta B; Erdogan M; Uyanik B; Canbek S; Ata P; Geckinli BB; Arslan Ates E; Alavanda C; Yesim Ozdemir S; Sezer O; Ozgon GO; Gurkan H; Guler K; Boga I; Kaya N; Alemdar A; Sayan M; Dundar M; Ergoren MC; Temel SG
    J Med Virol; 2022 Nov; 94(11):5225-5243. PubMed ID: 35811452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review.
    Li J; Wang Y; Liu Y; Zhang Z; Zhai Y; Dai Y; Wu Z; Nie X; Du L
    Eur J Med Res; 2022 Feb; 27(1):26. PubMed ID: 35193695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
    Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
    J Genet; 2021; 100(1):. PubMed ID: 33707363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients.
    Ravaioli S; Tebaldi M; Fonzi E; Angeli D; Mazza M; Nicolini F; Lucchesi A; Fanini F; Pirini F; Tumedei MM; Cerchione C; Viale P; Sambri V; Martinelli G; Bravaccini S
    Cell Transplant; 2020; 29():963689720968749. PubMed ID: 33108902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease.
    Singh H; Choudhari R; Nema V; Khan AA
    Microb Pathog; 2021 Jan; 150():104621. PubMed ID: 33278516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants in ACE2; potential influences on virus infection and COVID-19 severity.
    Bakhshandeh B; Sorboni SG; Javanmard AR; Mottaghi SS; Mehrabi MR; Sorouri F; Abbasi A; Jahanafrooz Z
    Infect Genet Evol; 2021 Jun; 90():104773. PubMed ID: 33607284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the clinical course of SARS-CoV-2 infections and ACE2 and TMPRSS2 expression and polymorphisms.
    Tug E; Fidan I; Bozdayi G; Yildirim F; Tunccan OG; Lale Z; Akdogan D
    Adv Clin Exp Med; 2024 Jan; 33(1):39-51. PubMed ID: 37326579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of specific
    Elemam NM; Bouzid A; Alsafar H; Ahmed SB; Hafezi S; Venkatachalam T; Eldohaji L; Al Hamidi T; Gerges PH; Halabi N; Hadj-Kacem H; Talaat IM; Taneera J; Sulaiman N; Maghazachi AA; Hamid Q; Hamoudi R; Saber-Ayad M
    Front Immunol; 2024; 15():1348229. PubMed ID: 38855114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy.
    Zarubin A; Stepanov V; Markov A; Kolesnikov N; Marusin A; Khitrinskaya I; Swarovskaya M; Litvinov S; Ekomasova N; Dzhaubermezov M; Maksimova N; Sukhomyasova A; Shtygasheva O; Khusnutdinova E; Radzhabov M; Kharkov V
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375616
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Abdelsattar S; Kasemy ZA; Ewida SF; Abo-Elsoud RAA; Zytoon AA; Abdelaal GA; Abdelgawad AS; Khalil FO; Kamel HFM
    Br J Biomed Sci; 2022; 79():10238. PubMed ID: 35996506
    [No Abstract]   [Full Text] [Related]  

  • 13. ACE2 and TMPRSS2 SARS-CoV-2 infectivity genes: deep mutational scanning and characterization of missense variants.
    Zhang L; Sarangi V; Liu D; Ho MF; Grassi AR; Wei L; Moon I; Vierkant RA; Larson NB; Lazaridis KN; Athreya AP; Wang L; Weinshilboum R
    Hum Mol Genet; 2022 Dec; 31(24):4183-4192. PubMed ID: 35861636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress.
    Rossi ÁD; de Araújo JLF; de Almeida TB; Ribeiro-Alves M; de Almeida Velozo C; Almeida JM; de Carvalho Leitão I; Ferreira SN; da Silva Oliveira J; Alves HJ; Scheid HT; Faffe DS; Galliez RM; de Ávila RE; Resende GG; Teixeira MM; ; da Costa Ferreira Júnior O; Castiñeiras TMPP; Souza RP; Tanuri A; Aguiar RS; Barroso SPC; Cardoso CC
    Sci Rep; 2021 May; 11(1):9658. PubMed ID: 33958627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analyses of ACE2 and TMPRSS2 gene: Implications for the risk to which vertebrate animals are susceptible to SARS-CoV-2.
    Huang C; Jiang Y; Yan J
    J Med Virol; 2021 Sep; 93(9):5487-5504. PubMed ID: 33974296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2: Understanding the Transcriptional Regulation of ACE2 and TMPRSS2 and the Role of Single Nucleotide Polymorphism (SNP) at Codon 72 of p53 in the Innate Immune Response against Virus Infection.
    Lodhi N; Singh R; Rajput SP; Saquib Q
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A low aldosterone/renin ratio and high soluble ACE2 associate with COVID-19 severity.
    Akin S; Schriek P; van Nieuwkoop C; Neuman RI; Meynaar I; van Helden EJ; Bouazzaoui HE; Baak R; Veuger M; Mairuhu RATA; van den Berg L; van Driel V; Visser LE; de Jonge E; Garrelds IM; Duynstee JFAB; van Rooden JK; Ludikhuize J; Verdonk K; Caliskan K; Jansen T; van Schaik RHN; Danser AHJ
    J Hypertens; 2022 Mar; 40(3):606-614. PubMed ID: 34862332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
    Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
    EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
    Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
    Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of ACE1, ACE2, and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis.
    Saengsiwaritt W; Jittikoon J; Chaikledkaew U; Udomsinprasert W
    Rev Med Virol; 2022 Jul; 32(4):e2323. PubMed ID: 34997794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.